Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Immune Network|December 31, 2016
Reference Values for a Panel of Cytokinergic and Regulatory Lymphocyte SubpopulationsVincenzo Sorrenti, Bruno Marenda, Stefano Fortinguerra, et al.
International Immunopharmacology|April 24, 2026
Serum amyloid A1 directly engages TLR4/MD-2 to trigger neuroinflammatory signaling in microglia culturesLaura Facci, Chiara Chemello, Emma Marcolin, et al.
Acta Pharmaceutica (Zagreb, Croatia)|June 8, 2017
Real-practice thromboprophylaxis in atrial fibrillationPaola Deambrosis, Alessandra Bettiol, Jenny Bolcato, et al.
Clinical Drug Investigation|July 26, 2018
Pattern of Use and Long-Term Safety of Tyrosine Kinase Inhibitors: A Decade of Real-World Management of Chronic Myeloid LeukemiaAlessandra Bettiol, Ettore Marconi, Niccolò Lombardi, et al.
Life Sciences|November 12, 2023
2-Pentadecyl-2-oxazoline inhibits lipopolysaccharide-induced microglia activation interfering with TLR4 signalingLaura Facci, Chiara Bolego, Chiara Chemello, et al.
Frontiers in Pharmacology|September 27, 2021
Pre- and Early Post-treatment With <i>Arthrospira platensis</i> (Spirulina) Extract Impedes Lipopolysaccharide-triggered Neuroinflammation in MicrogliaAnna Piovan, Jessica Battaglia, Raffaella Filippini, et al.
Journal of Neuroinflammation|December 31, 2015
Ligand engagement of Toll-like receptors regulates their expression in cortical microglia and astrocytesCarla Marinelli, Rosa Di Liddo, Laura Facci, et al.
Journal of Neuroinflammation|July 20, 2019
Ciprofloxacin and levofloxacin attenuate microglia inflammatory response via TLR4/NF-kB pathwayMorena Zusso, Valentina Lunardi, Davide Franceschini, et al.
Plos One|October 8, 2019
New oral anti-coagulants versus vitamin K antagonists in high thromboembolic risk patientsAnnachiara Bellin, Patrizia Berto, Sakis Themistoclakis, et al.
Pageof 7